Cargando…

Chemoresponse of de novo Acute Myeloid Leukemia to “7+3” Induction can Be Predicted by c-Myc-facilitated Cytogenetics

Background: Identifying patients with de novo acute myeloid leukemia (AML) who will probably respond to the “7 + 3” induction regimen remains an unsolved clinical challenge. This study aimed to identify whether c-Myc could facilitate cytogenetics to predict a “7 + 3” induction chemoresponse in de no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsiao, Tzu-Hung, Wang, Ren Ching, Lu, Tsai-Jung, Shih, Chien-Hung, Su, Yu-Chen, Tsai, Jia-Rong, Jhan, Pei-Pei, Lia, Cai-Sian, Chuang, Han-Ni, Chang, Kuang-Hsi, Teng, Chieh-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061304/ https://www.ncbi.nlm.nih.gov/pubmed/33897436 http://dx.doi.org/10.3389/fphar.2021.649267

Ejemplares similares

Evaluation of chemoresponse assays as predictive markers
por: Korn, E L, et al.
Publicado: (2015)

Cytogenetic Profile of de novo Acute Myeloid Leukemia Patients in Malaysia
por: Meng, Chin Yuet, et al.
Publicado: (2013)

Cytogenetic Characteristics of de novo Acute Myeloid Leukemia in Southern Vietnam
por: Thao, Lai Thi Thanh, et al.
Publicado: (2023)

Overview of a chemoresponse assay in ovarian cancer
por: Grendys, E. C., et al.
Publicado: (2014)

In vitro chemoresponse in metachronous pairs of gyneclologic cancers
por: Dalton, Heather J, et al.
Publicado: (2014)

Comment on: ‘Evaluation of chemoresponse assays as predictive markers'
por: Tian, C, et al.
Publicado: (2015)

Redefining Remission Induction Chemotherapy Ineligibility by Early Mortality in De Novo Acute Myeloid Leukemia
por: Li, You-Cheng, et al.
Publicado: (2021)

MYC amplification in leukemia detected by cytogenetics
por: Safranauskas, Roberta Maria da Silva Oliveira, et al.
Publicado: (2021)

Response to Comment on: ‘Evaluation of chemoresponse assays as predictive biomarkers'
por: Korn, E L, et al.
Publicado: (2015)

The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer
por: Matondo, Abel, et al.
Publicado: (2017)

Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults
por: Tsui, Sze P., et al.
Publicado: (2020)

Chemical Sensing and Chemoresponsive Pumping with Conical-Pore Polymeric Membranes
por: Bush, Stevie N., et al.
Publicado: (2020)

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia
por: Eisfeld, A-K, et al.
Publicado: (2017)

Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia
por: Yang, Wen-Chi, et al.
Publicado: (2013)

A circuit-dependent ROS feedback loop mediates glutamate excitotoxicity to sculpt the Drosophila motor system
por: Peng, Jhan-Jie, et al.
Publicado: (2019)

Expression of Heat Shock Protein 70 Modulates the Chemoresponsiveness of Pancreatic Cancer
por: Hyun, Jong Jin, et al.
Publicado: (2013)

miRNA Profiles as a Predictor of Chemoresponsiveness in Wilms’ Tumor Blastema
por: Watson, Jenny A., et al.
Publicado: (2013)

Chemoresponse after non-curative gastrectomy for M1 gastric cancer
por: Shin, Hyun Beak, et al.
Publicado: (2015)

Design of Chemoresponsive Soft Matter Using Hydrogen-Bonded Liquid Crystals
por: Yu, Huaizhe, et al.
Publicado: (2021)

Electrochemical Fine-Tuning of the Chemoresponsiveness of Langmuir–Blodgett Graphene Oxide Films
por: Devida, Juan M., et al.
Publicado: (2023)

Characterization of familial hypercholesterolemia in Taiwanese ischemic stroke patients
por: Tung, Hsin, et al.
Publicado: (2021)

Molecular cytogenetic analysis and clinical manifestations of a case with de novo mosaic ring chromosome 7
por: Tsai, Li-Ping, et al.
Publicado: (2011)

Towards first-principles molecular design of liquid crystal-based chemoresponsive systems
por: Roling, Luke T., et al.
Publicado: (2016)

Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis
por: Davidson, Brittany A., et al.
Publicado: (2016)

Cytogenetic and Morphological Analysis of De Novo Acute Myeloid Leukemia in Adults: A Single Center Study in Jordan
por: Ayesh, MH, et al.
Publicado: (2012)

Posaconazole for the prophylaxis of invasive aspergillosis in acute myeloid leukemia: Is it still useful outside the clinical trial setting?
por: Chen, Tsung-Chih, et al.
Publicado: (2020)

An 8-gene signature for prediction of prognosis and chemoresponse in non-small cell lung cancer
por: Shahid, Muhammad, et al.
Publicado: (2016)

Relation between mismatch repair status, chemoresponse, survival and anatomic location in gastroesophageal adenocarcinoma
por: Evaristo, Gertruda, et al.
Publicado: (2023)

The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer
por: Asare-Werehene, Meshach, et al.
Publicado: (2023)

Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients
por: Cuevas-Estrada, Berenice, et al.
Publicado: (2023)

Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC Oncoproteins
por: Chi, Ya-Hui, et al.
Publicado: (2021)

Computational analysis of novel drugs designed for use as acetylcholinesterase inhibitors and histamine H(3) receptor antagonists for Alzheimer's disease by docking, scoring and de novo evolution
por: CHEN, PO-YUAN, et al.
Publicado: (2012)

Identification and comparative analysis of long non-coding RNAs in the brain of fire ant queens in two different reproductive states
por: Tsai, Cheng-Hung, et al.
Publicado: (2022)

Cytogenetics’ impact on the prognosis of acute myeloid leukemia
por: Gupta, Monika, et al.
Publicado: (2019)

Laboratory Surge Response to the COVID-19 Pandemic: An Incident Command System Approach
por: Chuang, Han-Ni, et al.
Publicado: (2022)

Follow-up of the tumor load in patients with de novo chronic myeloid leukemia and in complete cytogenetic remission treated with imatinib in Colombia
por: Guevara, Gonzalo, et al.
Publicado: (2012)

Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities
por: Weinberg, Olga K., et al.
Publicado: (2018)

Analysis of RAS gene mutations in cytogenetically normal de novo acute myeloid leukemia patients reveals some novel alterations
por: Akram, Afia Muhammad, et al.
Publicado: (2021)

Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction
por: Wan, Ying-Wooi, et al.
Publicado: (2010)

Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants
por: Al Amri, Waleed S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2npuudgc2fserp8b35pnqfv14i